Correlation Between Molecular Partners and Aptorum Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Aptorum Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Aptorum Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Aptorum Group Ltd, you can compare the effects of market volatilities on Molecular Partners and Aptorum Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Aptorum Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Aptorum Group.

Diversification Opportunities for Molecular Partners and Aptorum Group

-0.06
  Correlation Coefficient

Good diversification

The 3 months correlation between Molecular and Aptorum is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Aptorum Group Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aptorum Group and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Aptorum Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aptorum Group has no effect on the direction of Molecular Partners i.e., Molecular Partners and Aptorum Group go up and down completely randomly.

Pair Corralation between Molecular Partners and Aptorum Group

Given the investment horizon of 90 days Molecular Partners AG is expected to generate 0.87 times more return on investment than Aptorum Group. However, Molecular Partners AG is 1.15 times less risky than Aptorum Group. It trades about 0.04 of its potential returns per unit of risk. Aptorum Group Ltd is currently generating about -0.25 per unit of risk. If you would invest  564.00  in Molecular Partners AG on September 3, 2024 and sell it today you would earn a total of  18.00  from holding Molecular Partners AG or generate 3.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Molecular Partners AG  vs.  Aptorum Group Ltd

 Performance 
       Timeline  
Molecular Partners 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Molecular Partners AG are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain essential indicators, Molecular Partners displayed solid returns over the last few months and may actually be approaching a breakup point.
Aptorum Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aptorum Group Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Molecular Partners and Aptorum Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Molecular Partners and Aptorum Group

The main advantage of trading using opposite Molecular Partners and Aptorum Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Aptorum Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptorum Group will offset losses from the drop in Aptorum Group's long position.
The idea behind Molecular Partners AG and Aptorum Group Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets